Hydroquinone, a bioreactive metabolite of benzene, inhibits apoptosis in myeloblasts

Stem Cells

Volumn 14, Issue 6, 1996, Pages 730-742

  Hazel, Betsy A ^a   Baum, Christine ^a   Kalf, George F ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Benzene metabolite; Hydroquinone; Inhibition of apoptosis; Myeloblasts

Indexed keywords

BENZENE; BENZOQUINONE; CYSTEINE PROTEINASE; DNA; DNA FRAGMENT; HYDROQUINONE; INTERLEUKIN 3; STAUROSPORINE;

ACUTE GRANULOCYTIC LEUKEMIA; AGAR GEL ELECTROPHORESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MOUSE; MYELOBLAST; NONHUMAN;

ANIMALIA;

EID: 0029826230     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.140730     Document Type: Article

References (51)

1. Aksoy M. Malignancies due to occupational exposure to benzene. Am J Ind Med 1985;7:395-402.
2. Arp EW, Wolf PH, Checkoway H. Lymphocyte leukemia and exposure to benzene and other solvents in the rubber industry. J Occup Med 1983;25:598-602.
3. Infante PF, White MC. Benzene: epidemiologic observations of leukemia by cell type and adverse effects associated with low-level exposure. Environ Health Perspect 1983;52:75-82.
4. Snyder R, Kalf GF. A perspective on benzene leukemogenesis. CRC Crit Rev Toxicol 1994;24:177-209.
5. Rickert E, Baker TS, Bus JS et al. Benzene disposition in the rat after benzene exposure by inhalation. Toxicol Appl Pharmacol 1979;49:417-423.
6. 14C-labeled benzene metabolites in the rat. Chem Biol Interact 1981;33:285-299.
7. Smart RC, Zannoni VG, DT-diaphorase and peroxidase influence the covalent binding of the metabolites of phenol, the major metabolite of benzene. Mol Pharmacol 1984;26:105-111.
8. Schlosser MJ, Kalf GF. Metabolic activation of hydroquinone by macrophage peroxidase. Chem Biol Interact 1989;72:191-207.
9. Smith MT, Yager JW, Steinmetz KL et al. Peroxidase-dependent metabolism of benzene's phenolic metabolites and its potential role in benzene toxicity and carcinogenicity. Environ Health Perspect 1989;82:23-29.
10. Irons RD, Neptun DA, Pfeifer RW. Inhibition of lymphocyte transformation and microtubule assembly by quinone metabolites of benzene: evidence for a common mechanism. J Reticuloendothel Soc 1981;30:359-372.
11. Pfeifer RW, Irons RD. Alteration of lymphocyte function by quinones through sulfhydryl-dependent disruption of microtubule assembly. Int J Immunopharmacol 1983;5:463-470.
12. Schwartz C, Snyder R, Kalf GF. The inhibition of mitochondrial DNA replication in vitro by the metabolites of benzene, hydroquinone and p-benzoquinone. Chem Biol Interact 1986;53:327-350.
13. Schlosser MJ, Shurina RD, Kalf GF. Prostaglandin H synthase catalyzed oxidation of hydroquinone to a sulfhydryl-binding and DNA-damaging metabolite. Chem Res Toxicol 1990;3:333-339.
14. Renz JF, Kalf GF. Role for interleukin-1 (IL-1) in benzene-induced hematotoxicity: inhibition of conversion of pre-IL-1α to mature cytokine in murine macrophages by hydroquinone and prevention of benzene-induced hematotoxicity in mice by IL-1α. Blood 1991;78:938-944.
15. Hazel BA, O'Connor A, Niculescu R et al. Benzene and its metabolite hydroquinone induce granulocytic differentiation in myeloblasts by interacting with cellular signaling pathways activated by granulocyte colony-stimulating factor. STEM CELLS 1995;13:295-310.
16. Irons RD, Stillman WS. Cell proliferation and differentiation in chemical leukemogenesis. STEM CELLS 1993;11:235-242.
17. Greenberger JS, Sakakeeny MA, Humphries RK et al. Demonstration of permanent factor-dependent multipotential (erythroid, neutrophil, basophil) hematopoietic progenitor cell lines. Proc Natl Acad Sci USA 1983;80:2931-2935.
18. Metcalf D. Multi-CSF-dependent colony formation by cells of a murine hematopoietic cell line: specificity and action of multi-CSF. Blood 1985;65:357-362.
19. Valtieri M, Tweardy DJ, Caracciolo D et al. Cytokine-dependent granulocytic differentiation. Regulation of proliferative and differentiative responses in a murine progenitor cell line. J Immunol 1987;138:3829-3835.
20. Collins SJ. The HL-60 promyelocytic cell line: proliferation, differentiation and cellular oncogene expression. Blood 1987;70:1233-1244.
21. Fernandez-Alnemeri T, Litwack G, Alnemeri E. Mch-2, a new member of the apoptotic Ced-3/ICE cysteine protease gene family. Cancer Res 1995;55:2737-2742.
22. Cleveland JL, Askew DS, Bello-Fernandez C et al. Regulation of apoptosis in interleukin-3-dependent myeloid progenitor cells. In: Mihich E, Schimke RT, eds. Apoptosis. New York: Plenum Press, 1994:85-93.
23. Gottlieb E, Haffner R, Yonish-Rouach E et al. Wild type p53 activity contributes to dependence on hematopoietic survival factors. In: Mihich E, Schimke RT, eds. Apoptosis. New York: Plenum Press, 1994:31-45.
24. Bertrand R, Solary E, O'Connor P et al. Induction of a common pathway of apoptosis by staurosporine. Exp Cell Res 1994;211:314-321.
25. Evan GI, Wyllie AH, Gilbert CS et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992;69:119-128.
26. Shi Y, Glynn JM, Guilbert LJ et al. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science 1992;257:212-214.
27. Bertrand R, Sarang M, Jenkin J et al. Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression. Cancer Res 1991;51:6280-6285.
28. Subrahmanyam VV, Sadler A, Suba E et al. Stimulation of in vitro bioactivation of hydroquinone by phenol in bone marrow cells. Drug Metab Dispos 1989;17:348-350.
29. + normal human hematopoietic cells. Blood 1993;82:2065-2078.
30. Bhat RV, Subrahmanyam VV, Sadler A et al. Bioactivation of catechol in rat and human bone marrow cells. Toxicol Appl Pharmacol 1988;94:297-304.
31. 4 receptor. Receptors and Signal Transduction 1996:6:1-12.
32. Yuan J, Shaham S, Ledoux S et al. The C. elegans cell death gene, ced-3, encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 1993;75:641-652.
33. Cerretti DP, Kozlosky CJ, Mosley et al. Molecular cloning of the interleukin-1β converting enzyme. Science 1992;256:97-100.
34. Thornberry NA, Bull HG, Calaycay JR et al. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 1992;356:768-774.
35. Kumar S, Kinoshita M, Noda M et al. Induction of apoptosis by the mouse Nedd2 gene which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene, ced-3 and the mammalian IL-1β-converting enzyme. Genes Dev 1994;8:1613-1626.
36. Wang L, Miura M, Bergeron L et al. Ich-1, an Ice/ced-3-related gene encodes both positive and negative regulators of cell death. Cell 1994;78:739-750.
37. Fernandes-Alnemri T, Litwack G, Alnemri ES. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1β-converting enzyme. J Biol Chem 1994;49:30761-30764.
38. Fernandes-Alnemri T, Takahashi A, Armstrong R et al. Mch3, a novel human apoptotic cysteine protease highly related to CPP32. Cancer Res 1995;55:6045-6052.
39. Faucheu C, Diu A, Chan AWE et al. A novel human protease similar to the interleukin-1β-converting enzyme induces apoptosis in transfected cells. EMBO J 1995;14:1914-1922.
40. Kamens J, Paskind M, Huguinin M et al. Identification and characterization of Ich-2, a novel member of the interleukin-1β-converting enzyme family of cysteine proteases. J Biol Chem 1995;270:15250-15256.
41. Munday NA, Vaillancourt JP, Ali A et al. Molecular cloning and pro-apoptotic activity of ICErel-II and ICErel-III members of the ICE/CED family of cysteine proteases. J Biol Chem 1995;270:15870-15876.
42. Komiyama T, Ray CA, Pickup DJ et al. Inhibition of interleukin-1β-converting enzyme by the cowpox virus serpin, CrmA. J Biol Chem 1994;269:19331-19337.
43. Ray CA, Black RA, Kronheim S et al. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1β-converting enzyme. Cell 1992;69:597-604.
44. Clem RJ, Miller LK. Control of programmed cell death by the baculovirus genes p35 and iap. Mol Cell Biol 1995;14:5212-5222.
45. Hay BA, Wolff T, Rubin GM. Expression of baculovirus p35 prevents cell death in Drosophila. Development 1994;120:2121-2129.
46. Rabizadeh S, LaCount DJ, Friesen PD et al. Expression of the baculovirus p35 gene inhibits mammalian neuronal cell death. J Neurochem 1993;61:2318-2321.
47. Sugimoto AP, Friesen PD, Rothman JH. Baculovirus p35 prevents developmentally programmed cell death and rescues a Ced-9 mutant in the nematode, Caenorhabditis elegans. EMBO J 1994;13:2023-2028.
48. Bump NJ, Hackett M, Hugunin M et al. Inhibition of ICE family of proteases by baculovirus anti-apoptotic protein. Science 1995;269:1885-1888.
49. Xue D, Harvitz HR. Inhibition of Caenorhabditis elegans cell-death protease CED-3 by a CED-3 cleavage site in baculovirus p35 protein. Nature 1995;377:248-251.
50. Niculescu R, Bradford HN, Colman RW et al. Inhibition of the conversion of pre-interleukins-1α and 1β to mature cytokines by p-benzoquinone, a metabolite of benzene. Chem Biol Interact 1995;98:211-222.
51. Hu Q, Trevisan M et al. c-kit expression enhances the leukemogenic potential of 32D cells. J Clin Invest 1995;95:2530-2538.